Gilead Sciences: Black HIV/AIDS Awareness Day
Gilead Sciences emphasizes the ongoing efforts to address the disproportionate impact of HIV on Black communities during Black HIV/AIDS Awareness Day. The company acknowledges significant progress in education and access to screening, prevention, and care but highlights the need for continued work in these areas. As a research-based biopharmaceutical organization, Gilead aims to transform care for life-threatening illnesses globally, maintaining operations in over 35 countries with its headquarters in Foster City, California. Gilead's commitment remains strong in combating HIV/AIDS and promoting health equity.
- None.
- None.
NORTHAMPTON, MA / ACCESSWIRE / February 23, 2023 / Gilead Sciences:
This Black HIV/AIDS Awareness Day, we recognize the major strides made to combat the disproportionate impact of HIV on Black communities - but there is more work to do.
Learn why access and education around screening, prevention and care are important.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View source version on accesswire.com:
https://www.accesswire.com/740523/Gilead-Sciences-Black-HIVAIDS-Awareness-Day
FAQ
What is Gilead Sciences' focus on HIV/AIDS awareness?
What initiatives are highlighted by Gilead on Black HIV/AIDS Awareness Day?
Where is Gilead Sciences headquartered?
